Breast cancer cells can lay the groundwork for their own metastasis throughout the body by coaxing cells within lymphatic vessels to send out tumor-welcoming signals.
The BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared with the use of conventional IHC-FISH pathology tests, according to a new study.
One-third of women who are given information about the potential for over-diagnosis through the National Health Services (NHS) breast screening program may not completely understand the risks involved.
Screening women for breast cancer up to age 75 may lead to overdiagnosis and overtreatment.
Postmenopausal women with a diverse gut microbiome have higher levels of estrogen metabolites.
Clinical trial focusing on pre-surgery positron emission mammography. Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer
Clinical trial focusing on breast cancer information registry. A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer (BCCR)
Clinical trial focusing on breast density and breast cancer risk. Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
Clinical trial focusing on genomic testing for primary breast cancer. Genomic Testing for Primary Breast Cancer
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|